Neoprobe’s largest backer gears up for proxy war March 23, 2011 By MedCity News Leave a Comment Neoprobe Corp.’s (NYSE:NEOP) largest shareholder said it’s considering launching a proxy fight aimed at installing three new directors on the cancer diagnostics company’s board.